Mary-Ann Lumsden

No ORCID on file · 2 papers in corpus

other 2023

Ulipristal acetate versus levonorgestrel-releasing intrauterine system for heavy menstrual bleeding (UCON): a randomised controlled phase III trial

EClinicalMedicine ·doi:10.1016/j.eclinm.2023.101995

BACKGROUND: Heavy menstrual bleeding affects one in four women and negatively impacts quality of life. Ulipristal acetate is prescribed to treat symptoms associated with uterine fibroids. We compared the effectiveness of ulipristal acetate …

article 2005

The hormone replacement therapy controversy

·doi:10.1111/j.1471-0528.2005.00613.x